A political decision is needed regarding the production of critical drugs in Poland, emphasizes Barbara Misiewicz-Jagielak, manager of external relations at Polpharma SA and vice president of the National Drug Manufacturers, in the podcast "Rzecz o Zdrowiu". In an interview with "Rz", she draws attention to the request to coordinate efforts for the country's drug safety.
